Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cellsSumati Gupta, Sunil Sharma, Mohan R. Kaadige et al.|Oncotarget|2018Cited by 27
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i> -Mutated Advanced Urothelial CarcinomaSumati Gupta, Sunil Sharma, Lisa M. Pappas et al.|Molecular Cancer Therapeutics|2018Cited by 24
Abstract 1932: Discovery of ENPP1 inhibitors as agonists of STING pathwaySunil Sharma, Hariprasad Vankayalapti, Alexis Weston et al.|Cancer Research|2018Cited by 6
Abstract LB323: Inhibition of ENPP1 using small molecule, SR-8541A, enhances the effect of checkpoint inhibition in cancer modelsAlexis Weston, Sunil Sharma, Trason Thode et al.|Cancer Research|2023Cited by 5
Clinical and translational investigation of pan-HDAC inhibition in advanced urothelial carcinoma (UC).Sumati Gupta, Neeraj Agarwal, Daniel J. Albertson et al.|Journal of Clinical Oncology|2017Cited by 2